A Study of the Combination Vorinostat With Lenalidomide, Bortezomib and Dexamethasone for Patients With Newly Diagnosed Multiple Myeloma

Femme et Homme

| Pays :
| Organes :
| Spécialités :

Extrait

The purpose of the study is to evaluate the clinical effectiveness and side effects of the vorinostat, bortezomib, lenalidomide, and dexamethasone investigational combination.

Critère d'inclusion

Multiple myeloma

Liens

nct
ictrp